Sign in
Taking people in United StatesNo phase

Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds

Key facts

Who runs it
Biodynamik, Inc
Where
Jacksonville, United StatesSee the site
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
15 Sept 2026
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Biodynamik XT3
Record updated
14 September 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 29 criteriaShow less

Who can take part

  • Adults (>=22 years)
  • Chronic diabetic foot ulcer wound persisting >=12 weeks and less than 104 weeks refractory to standard wound care
  • Wound location within distal 1/3 tibia and below including foot
  • Wound stages: WiFi >= 3
  • At least one patent lower extremity tibial vessel (after revascularization if needed)
  • Able to provide informed consent and comply with study procedures

Who cannot take part

  • Corticosteroids >10mg prednisone equivalent daily for >2 weeks
  • TNF-inhibitors or JAK inhibitors or chemotherapy-dose methotrexate
  • Current participation in another investigational study (drug or device)
  • Active systemic infection (positive blood cultures)
  • End Stage Renal Disease requiring dialysis
  • Severe hepatic impairment defined by patient on a transplant list, MELD > 20 or Child's class C
  • A history of conditions that may impair wound healing in the opinion of the Investigator, for example, autoimmune disorders, renal failure patients on dialysis, or medications that impair the healing process
  • Active local wound infection as defined by erythema greater than 0.5 cm from the wound margin AND at least one other localized sign of inflammation (purulent discharge, induration, localized warmth, or pain/tenderness)
  • Renal function values; eGFR: <15ml/min and; Creatinine: >6mg/dL and; BUN: >50 mg/dL
  • Lab values of Serum albumin less than 2.5 g/dL or hemoglobin less than 8.0 g/dL or platelet count less than 75,000/μL
  • Immunocompromised (WBC <4) or undergoing active chemotherapy
  • Hemoglobin A1c >10
  • Severe sepsis (2 out of 4 SIRS criteria with impact on organ dysfunction)
  • Subacute lower extremity wound <12 weeks with or without standard wound cares
  • Internal hardware within 10cm of possible TTT placement
  • Most proximal aspect of wound within 10cm of most distal pin of possible TTT placement
  • Wounds less than 1 cm3 or greater than 30 cm3
  • Wounds that are circumferential as defined as a wound involving 360° of the limb circumference, with complete circumferential wounds defined as 360° involvement
  • Patients with osteomyelitis in the ipsilateral tibia at planned corticotomy site
  • Cognitive or social limitations precluding consent or follow-up
  • BMI <18.5 kg/m2
  • Pregnant, lactating, or planning to become pregnant
  • Life expectancy less than 12 months

Where in United States

  • Mayo ClinicJacksonville, United StatesContact: Lauren EvansTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in patients with chronic ischemic and diabetic lower extremity ulcers. This study will assess wound healing outcomes and limb preservation in a population with limited therapeutic alternatives.

The 2 groups in the trial

  • Standard of Care (control)No study treatment, for comparison

    Standard Wound Care

  • Standard Wound Care plus TTTTreatment being tested

    Treatment: Biodynamik XT3

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
SMILE - TTT: Surgical MIcrovascularization of Lower Extremities for Diabetic Foot Ulcers - Transverse Tibial Transport Study
Record updated
14 September 2026